CHE391L/S13/Genome Editing: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
No edit summary
No edit summary
Line 7: Line 7:
Genomic insertions can also be generated in higher eukaryotes using homologous recombination, but the process is significantly more involved.  Knockout mice have been a staple of genetics research since the 1980s, but they can take upwards of a year to generate.  The process begins with embryonic stem cells (ESCs) harvested from a mouse blastocyst.  They are then transfected with insert DNA by electroporation and successfully recombined cells are selected using an antibiotic such as neomycin.  The surviving ESCs are then injected into another blastocyst and implanted into a surrogate mouse's uterus.  Some of the resulting pups will be chimeric animals with a portion of their cells containing the modification.  Subsequent breeding of the chimeras allows for generation of a knockout animal.
Genomic insertions can also be generated in higher eukaryotes using homologous recombination, but the process is significantly more involved.  Knockout mice have been a staple of genetics research since the 1980s, but they can take upwards of a year to generate.  The process begins with embryonic stem cells (ESCs) harvested from a mouse blastocyst.  They are then transfected with insert DNA by electroporation and successfully recombined cells are selected using an antibiotic such as neomycin.  The surviving ESCs are then injected into another blastocyst and implanted into a surrogate mouse's uterus.  Some of the resulting pups will be chimeric animals with a portion of their cells containing the modification.  Subsequent breeding of the chimeras allows for generation of a knockout animal.


Recombination alone is generally not a viable strategy for genome editing in non-ESC cells, including tissue culture cells and live animals due to a high ratio of off-target insertions, but the process can be greatly enhanced if the insertion site is cleaved to generate a double-stranded break.  Several technologies exist to generate these breaks on a sequence specific basis, including zinc finger nucleases (ZFNs), transcription activator-like nucleases (TALENs), and recently developed CRISPR/Cas9 system.
Recombination alone is generally not a viable strategy for genome editing in non-ESC cells, including tissue culture cells and live animals due to a high ratio of off-target insertions, but the process can be greatly enhanced if the insertion site is cleaved to generate a double-stranded break.  Several technologies exist to generate these breaks on a sequence specific basis, including zinc finger nucleases (ZFNs), transcription activator-like nucleases (TALENs), and recently developed CRISPR/Cas9 system. <cite>Mussolino13</cite>


==Previously Existing Nuclease Technologies==
==Previously Existing Nuclease Technologies==
Line 37: Line 37:
<biblio>
<biblio>


#Mussolino13 pmid=23471067
//Comparison of ZFN, TALEN, and RGEN technologies
#Santiago08 pmid=18359850
#Santiago08 pmid=18359850
//Zinc finger nuclease editing in CHO cells
//Zinc finger nuclease editing in CHO cells
</biblio>
</biblio>

Revision as of 07:05, 8 April 2013


Introduction

The ability to alter the genomes of living organisms has been critical to our understanding of genetics and the development of synthetic biology as a viable field. In it's simplest form, genome editing involves generation of gene knockouts, where expression is eliminated through insertion or a removal of a region of genomic DNA, or knockins, where a new coding region is inserted to produce a novel gene product. This process is fairly straightforward in bacteria and yeast, where a cell's own homologous recombination machinery can be used to make genomic insertions, albeit with low efficiency. To carry this out, the cells are transformed with exogenous DNA (usually on a plasmid) containing the desired insertion sequence flanked by homology regions complementary to the target site sequences. Because very few cells undergo successful recombination, the inserted sequence must contain a selectable marker, such as an antibiotic resistance gene, to facilitate selection of modified cells. Thus, most knockouts are generated simply by inserting a marker in place of an existing gene, thus eliminating its expression.

Genome Editing in Higher Eukaryotes=

Genomic insertions can also be generated in higher eukaryotes using homologous recombination, but the process is significantly more involved. Knockout mice have been a staple of genetics research since the 1980s, but they can take upwards of a year to generate. The process begins with embryonic stem cells (ESCs) harvested from a mouse blastocyst. They are then transfected with insert DNA by electroporation and successfully recombined cells are selected using an antibiotic such as neomycin. The surviving ESCs are then injected into another blastocyst and implanted into a surrogate mouse's uterus. Some of the resulting pups will be chimeric animals with a portion of their cells containing the modification. Subsequent breeding of the chimeras allows for generation of a knockout animal.

Recombination alone is generally not a viable strategy for genome editing in non-ESC cells, including tissue culture cells and live animals due to a high ratio of off-target insertions, but the process can be greatly enhanced if the insertion site is cleaved to generate a double-stranded break. Several technologies exist to generate these breaks on a sequence specific basis, including zinc finger nucleases (ZFNs), transcription activator-like nucleases (TALENs), and recently developed CRISPR/Cas9 system. [1]

Previously Existing Nuclease Technologies

Existing nuclease-based technologies require recognition of the genomic target site by a sequence-specific DNA binding domain. Both ZFNs and TALENs use DNA binding proteins modules tethered to an endonuclease domain to generate breaks at the correct positions, though off-target cleavage does occur due to the limited length of the recognition sequence and flexibility of DNA-binding specificity from different modules. Double-stranded breaks generated by the nucleases can be repaired through homology directed repair (HDR) which allows insertion of a new sequence with flanking homology arms, or by nonhomologous end joining (NHEJ), an imperfect process that often results in gene knockouts without any additional insertion.

Zinc Finger Nucleases (ZFNs)

Zinc finger nucleases

Transcription Activator-Like Effector Nucleases (TALENs)

For information on additional non-nuclease genome editing techonologies see:
Recombinant Adeno-Associated Virus
Targetrons

The CRISPR System

Phage/Plasmid Immunity

CRISPR/Cas9 Genome Editing

Future Directions

iGEM Connections

References

  1. Mussolino C and Cathomen T. RNA guides genome engineering. Nat Biotechnol. 2013 Mar;31(3):208-9. DOI:10.1038/nbt.2527 | PubMed ID:23471067 | HubMed [Mussolino13]

    Comparison of ZFN, TALEN, and RGEN technologies

  2. Santiago Y, Chan E, Liu PQ, Orlando S, Zhang L, Urnov FD, Holmes MC, Guschin D, Waite A, Miller JC, Rebar EJ, Gregory PD, Klug A, and Collingwood TN. Targeted gene knockout in mammalian cells by using engineered zinc-finger nucleases. Proc Natl Acad Sci U S A. 2008 Apr 15;105(15):5809-14. DOI:10.1073/pnas.0800940105 | PubMed ID:18359850 | HubMed [Santiago08]

    Zinc finger nuclease editing in CHO cells

All Medline abstracts: PubMed | HubMed